Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Daiichi Sankyo
Farmers Insurance
QuintilesIMS
Dow
Fuji
Mallinckrodt
Chinese Patent Office
US Army

Generated: April 25, 2018

DrugPatentWatch Database Preview

CARDRASE Drug Profile

« Back to Dashboard

When do Cardrase patents expire, and when can generic versions of Cardrase launch?

Cardrase is a drug marketed by Pharmacia And Upjohn and is included in one NDA.

The generic ingredient in CARDRASE is ethoxzolamide. Additional details are available on the ethoxzolamide profile page.
Drug patent expirations by year for CARDRASE
Medical Subject Heading (MeSH) Categories for CARDRASE
Synonyms for CARDRASE
2-Benzothiazolesulfonamide, 6-ethoxy-
2179AH
3caj
3dcw
3dd0
3mdz
4-27-00-04404 (Beilstein Handbook Reference)
452-35-7
6-(ethyloxy)-1,3-benzothiazole-2-sulfonamide
6-Ethoxy-1,3-benzothiazole-2-sulfonamide
6-Ethoxy-1,3-benzothiazole-2-sulfonamide #
6-Ethoxy-2-benzothiazole8ulfonamide
6-Ethoxy-2-benzothiazolesulfonamide
6-Ethoxy-2-benzothiazolesulfonamide, 97%
6-Ethoxy-benzothiazole-2-sulfonic acid amide
6-Ethoxybenzo[d]thiazole-2-sulfonamide
6-Ethoxybenzothiazole-2-sulfonamide
6-Ethoxybenzothiazole-2-sulphonamide
6-Ethoxyzolamide
AB00383049_12
AB00383049_13
AC1L1FLZ
ACM452357
AI3-50805
AK396201
AKOS015915628
AN-17243
Athamid
BDBM10882
Benzothiazole, 6-ethoxy-2-sulfonamide-
BRN 0212240
C-44272
C9H10N2O3S2
Cardrase (TN)
CAS-452-35-7
CCG-213432
CHEBI:101096
CHEMBL18
CS-7836
CTK3I9197
D02441
D05FEU
D07INV
DB00311
Diuretic C
DSSTox_CID_3021
DSSTox_GSID_23021
DSSTox_RID_76834
DTXSID1023021
EINECS 207-199-5
Ethamide
Ethoxazolamide
Ethoxyzolamide
ethoxzolamide
Ethoxzolamide (EZA)
Ethoxzolamide, EZM
Ethoxzolamide, United States Pharmacopeia (USP) Reference Standard
Etoxzolamide
EZL
FT-0707866
Glaucotensil
GTPL6814
HE011235
HMS2093J03
HMS2094M03
HMS2233N09
HMS3373K15
HSDB 3268
HY-B1480
I14-54193
InChI=1/C9H10N2O3S2/c1-2-14-6-3-4-7-8(5-6)15-9(11-7)16(10,12)13/h3-5H,2H2,1H3,(H2,10,12,13
LS-40823
MCULE-3766215049
MFCD00057089
Mingoral
MLS000028637
MLS001077357
NCGC00018249-01
NCGC00018249-02
NCGC00018249-03
NCGC00018249-04
NCGC00018249-05
NCGC00022533-04
NCGC00186657-01
NSC 10679
NSC-10679
NSC-759129
NSC10679
NSC759129
Opera_ID_1207
OUZWUKMCLIBBOG-UHFFFAOYSA-N
Pharmakon1600-01505426
Redupresin
SBI-0206851.P001
SCHEMBL63941
SMR000059148
SR-01000000236
SR-01000000236-2
ST086115
ST51007023
Tox21_110848
Tox21_110848_1
U-4191
UNII-Z52H4811WX
Urea, N-[5-(1,1-dimethylethyl)-3-isoxazolyl]-N'-[4-[7-[2-(4-morpholinyl)ethoxy]imidazo[2,1-b]benzothiazol-2-yl]phenyl]-
WLN: T56 BN DSJ CSZW GO2
Z52H4811WX
ZB001796
ZINC56721

US Patents and Regulatory Information for CARDRASE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn CARDRASE ethoxzolamide TABLET;ORAL 011047-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn CARDRASE ethoxzolamide TABLET;ORAL 011047-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Cipla
Queensland Health
Johnson and Johnson
Argus Health
Deloitte
Medtronic
Farmers Insurance
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.